Atypical Teratoid/Rhabdoid Tumor

Observed

→ investigated in trials for

Etoposidesmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thiotepasmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tazemetostatsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gemcitabinesmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalansmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methotrexatesmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ribociclibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Topotecansmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bortezomibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Busulfansmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cediranibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panobinostatsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sonidegibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tamoxifensmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trametinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Atypical Teratoid/Rhabdoid Tumor studied in …STUDIED_INderived10 of 42show all (up to 200)
→ studied in	NCT04868799completed Finding New Targets by Proteomic Approaches (InnovRT1) · condition mapped ALIAS · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT06465199Phase 1/Phase 2 · recruiting Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT07390539Phase 1 · recruiting B7-H3.CD28Z.CART in CNS Neoplasms · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02114229Phase 2 · active not recruiting Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT05286801Phase 1/Phase 2 · active not recruiting Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT05835687Phase 1 · active not recruiting Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ALIAS · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT04416568Phase 2 · active not recruiting Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT07447076Phase 2 · recruiting Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT) · condition mapped CURATED_BROADER · 42 trials mapped (16 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →

Atypical Teratoid/Rhabdoid Tumor studied in …STUDIED_INderived10 of 42show all (up to 200)

→ studied in

NCT04868799completed

Finding New Targets by Proteomic Approaches (InnovRT1) · condition mapped ALIAS · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT06465199Phase 1/Phase 2 · recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT07390539Phase 1 · recruiting

B7-H3.CD28Z.CART in CNS Neoplasms · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT02114229Phase 2 · active not recruiting

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT05286801Phase 1/Phase 2 · active not recruiting

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT06942039early Phase 1 · recruiting

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT05835687Phase 1 · active not recruiting

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT03874455no longer available

Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ALIAS · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT04416568Phase 2 · active not recruiting

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers · condition mapped ONTOLOGY_EXACT · 42 trials mapped (16 active)

—

Observed

→ studied in

NCT07447076Phase 2 · recruiting

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT) · condition mapped CURATED_BROADER · 42 trials mapped (16 active)

—

Observed